Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
6.20
-2.19 (-26.10%)
At close: Nov 13, 2026, 4:00 PM EST
6.10
-0.10 (-1.61%)
After-hours: Nov 13, 2026, 7:55 PM EST

Candel Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
203.12119.73102.6535.4170.0682.64
Cash & Short-Term Investments
203.12119.73102.6535.4170.0682.64
Cash Growth
133.57%16.63%189.88%-49.45%-15.23%135.76%
Prepaid Expenses
4.241.661.151.381.892.3
Total Current Assets
207.35121.39103.836.871.9584.95
Property, Plant & Equipment
3.283.32.734.025.483.84
Other Long-Term Assets
0.480.50.330.380.270.42
Total Assets
211.11125.2106.8741.277.6989.21

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
2.541.130.240.420.381.59
Accrued Expenses
7.276.874.723.964.723.44
Current Portion of Long-Term Debt
--9.98.89--
Current Portion of Leases
0.470.450.570.510.46-
Other Current Liabilities
17.10.5522.110.40.050.33
Total Current Liabilities
27.39937.5314.185.625.36
Long-Term Debt
48.247.132.612.3820.850.56
Long-Term Leases
1.11.460.410.971.49-
Long-Term Unearned Revenue
0.020.09--0.14-
Other Long-Term Liabilities
2.8115.6-0.921.8819.15
Total Liabilities
79.5273.2740.5428.4629.9825.07

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.790.550.470.290.290.29
Additional Paid-In Capital
431.28282.21258.51149.93146.96144.15
Retained Earnings
-300.03-230.39-192.21-137.03-99.09-80.3
Treasury Stock
-0.45-0.45-0.45-0.45-0.45-
Total Common Equity
131.5951.9266.3312.7547.7164.14
Shareholders' Equity
131.5951.9266.3312.7547.7164.14
Total Liabilities & Equity
211.11125.2106.8741.277.6989.21

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
49.7749.0313.4722.7622.80.56
Net Cash (Debt)
153.3570.789.1812.6547.2682.08
Net Cash Growth
92.27%-20.73%604.95%-73.23%-42.43%140.66%
Net Cash Per Share
2.281.332.820.441.644.35
Filing Date Shares Outstanding
78.4573.2547.2429.3528.9228.69
Total Common Shares Outstanding
78.4554.946.8129.0928.9228.69
Working Capital
179.97112.3966.2822.6166.3379.58
Book Value Per Share
1.680.951.420.441.652.24
Tangible Book Value
131.5951.9266.3312.7547.7164.14
Tangible Book Value Per Share
1.680.951.420.441.652.24
Machinery
2.832.192.162.192.51.19
Leasehold Improvements
3.013.013.113.113.062.99
SEC Filings: 10-K · 10-Q